Uncategorized
#ACC26: Merck touts comparator data for oral cholesterol drug
Merck’s drug enlicitide beat a handful of commonly used cholesterol-lowering drugs in a comparator trial, inching it closer to becoming the first oral PCSK9 inhibitor.
The company announced back in June that …